StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Buy the Puma Biotechnology (PBYI) Dip - Citi
May 10, 2018 12:32 PM
Citi analyst Yigal Nochomovitz came out to defend Puma Biotechnology (NASDAQ: PBYI), saying the sell-off is overdone and to buy ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Hot Comments
Trader Talk
Next Articles
Puma Biotechnology (PBYI) PT Lowered to $87 at Stifel
May 10, 2018 5:09 PM
Puma Biotechnology (PBYI) PT Lowered to $111 at BofA/Merrill Lynch
May 10, 2018 6:28 AM
Puma Biotech (PBYI) Tops Q1 EPS by 24c
May 9, 2018 4:10 PM
Puma Biotechnology Reports First Quarter 2018 Financial Results
May 9, 2018 4:05 PM
Form 8-K PUMA BIOTECHNOLOGY, INC. For: May 08
May 9, 2018 4:03 PM
Puma Biotechnology to Present at Bank of America Merrill Lynch Health Care Conference 2018
May 8, 2018 4:15 PM
